HIV Citation List: February 18, 2011- March 3, 2011
Pubmed citations:
1. Inhibition of Early Stages of HIV-1 Assembly by INI1/hSNF5 Transdominant Negative Mutant S6. Cano, J. and G.V. Kalpana. Journal of Virology, 2011. 85(5): p. 2254-2265; PMID[21159874].
[Pubmed], HIV_0218-030311.
2. Discovery of novel anti-HIV active G-quadruplex-forming oligonucleotides. Di Fabio, G., J. D'Onofrio, M. Chiapparelli, B. Hoorelbeke, D. Montesarchio, J. Balzarini, and L. De Napoli. Chemical Communications (Cambridge), 2011. 47(8): p. 2363-2365; PMID[21305065].
[Pubmed], HIV_0218-030311.
3. Structure of the HIV-1 Full-Length Capsid Protein in a Conformationally Trapped Unassembled State Induced by Small-Molecule Binding. Du, S., L. Betts, R. Yang, H. Shi, J. Concel, J. Ahn, C. Aiken, P. Zhang, and J.I. Yeh. Journal of Molecular Biology, 2011. 406(3): p. 371-386; PMID[21146540]
[Pubmed], HIV_0218-030311.
4. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase(RT)-associated DNA polymerase and Ribonuclease H (RNase H) activities effective also on the RNase H activity of non-nucleoside resistant RTs. Esposito, F., T. Kharlamova, S. Distinto, L. Zinzula, Y.C. Cheng, G. Dutschman, G. Floris, P. Markt, A. Corona, and E. Tramontano. FEBS Journal, 2011. [Epub ahead of print]; PMID[21348941].
[Pubmed], HIV_0218-030311.
5. Synthesis of chroman aldehydes that inhibit HIV. Kraus, G.A., J. Mengwasser, W. Maury, and C. Oh. Bioorganic and Medicinal Chemistry Letters, 2011. 21(5): p. 1399-1401; PMID[21306897].
[Pubmed], HIV_0218-030311.
6. Vipirinin, a coumarin-based HIV-1 VPR inhibitor, interacts with a hydrophobic region of VPR. Ong, E.B., N. Watanabe, A. Saito, Y. Futamura, K.H. Abd El Galil, A. Koito, N. Najimudin, and H. Osada. Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21357691].
[Pubmed], HIV_0218-030311.
7. HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less efficient mechanism of gp120-CCR5 engagement that attenuates macrophage-tropism. Roche, M., M.R. Jakobsen, J. Sterjovski, A. Ellett, F. Posta, B. Lee, B. Jubb, M. Westby, S.R. Lewin, P.A. Ramsland, M.J. Churchill, and P.R. Gorry. Journal of Virology, 2011. [Epub ahead of print]; PMID[21345957].
[Pubmed], HIV_0218-030311.
8. A mammalian two-hybrid system-based assay for small-molecular HIV fusion inhibitors targeting gp41. Shui, X., X. Lu, Y. Gao, C. Liu, F. Ren, Q. Jiang, H. Zhang, B. Zhao, and Z. Zheng. Antiviral Research, 2011. [Epub ahead of print]; PMID[21352856].
[Pubmed], HIV_0218-030311.
9. Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004 - 2010. Singh, I.P. and S.K. Chauthe. Expert Opinion on Therapeutic Patents, 2011. 21(3): p. 399-416; PMID[21342055].
[Pubmed], HIV_0218-030311.
10. Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication. Skerlj, R., G. Bridger, E. McEachern, C. Harwig, C. Smith, A. Kaller, D. Veale, H. Yee, K. Skupinska, R. Wauthy, L. Wang, I. Baird, Y. Zhu, K. Burrage, W. Yang, M. Sartori, D. Huskens, E.D. Clercq, and D. Schols. Bioorganic & Medicinal Chemistry Letters, 2011. 21(5): p. 1414-1418; PMID[21295470].
[Pubmed], HIV_0218-030311.
11. Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1. Tallant, M.D., M. Duan, G.A. Freeman, R.G. Ferris, M.P. Edelstein, W.M. Kazmierski, and P.J. Wheelan. Bioorganic & Medicinal Chemistry Letters, 2011. 21(5): p. 1394-1398; PMID[21292480].
[Pubmed], HIV_0218-030311.
12. Synthesis and Antiviral Evaluation of New N-acylhydrazones Containing Glycine Residue. Tian, B., M. He, Z. Tan, S. Tang, I. Hewlett, S. Chen, Y. Jin, and M. Yang. Chem Biol Drug Des, 2011. 77(3): p. 189-198; PMID[21306567].
[Pubmed], HIV_0218-030311.
13. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads. Vadivelan, S., T.N. Deeksha, S. Arun, P.K. Machiraju, R. Gundla, B.N. Sinha, and S.A. Jagarlapudi. European Journal of Medicinal Chemistry, 2011. 46(3): p. 851-859; PMID[21272964].
[Pubmed], HIV_0218-030311.
14. 4'C-methyl-2'-deoxyadenosine and 4'C-ethyl-2'-deoxyadeonosine Inhibit HIV-1 Replication. Vu, B.C., P.L. Boyer, M.A. Siddiqui, V.E. Marquez, and S.H. Hughes. Antimicrobial Agents & Chemotherapy, 2011. [Epub ahead of print]; PMID[21343443].
[Pubmed], HIV_0218-030311.
ISI Web of Knowledge citations:
15. Synthesis and Bioactivity of N-glycosyl-N '-(4-aryithiazol-2-yl) Aminoguanidines. Chen, H.M., Y.W. Zhao, and L.H. Cao. Journal of the Chinese Chemical Society, 2010. 57(5A): p. 1085-1090; ISI[000285525900020],
[WOS], HIV_0218-030311.
16. In vitro antiviral activity of diterpenes isolated from the Brazilian brown alga Canistrocarpus cervicornis. Vallim, M.A., J.E. Barbosa, D.N. Cavalcanti, J.C. De-Paula, V. da Silva, V.L. Teixeira, and I. Paixao. Journal of Medicinal Plants Research, 2010. 4(22): p. 2379-2382; ISI[000285690000011],
[WOS], HIV_0218-030311.
17. Recent Advances and Future Perspectives of Triazole Analogs as Promising Antiviral Agents. Kharb, R., M.S. Yar, and P.C. Sharma. Mini-Reviews in Medicinal Chemistry, 2011. 11(1): p. 84-96; ISI[000286221500007].
[WOS], HIV_0218-030311.
18. Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hexahydrofuropyranol-Derived High Affinity P-2 Ligands: Structure-Activity Studies and Biological Evaluation. Ghosh, A.K., B.D. Chapsal, A. Baldridge, M.P. Steffey, D.E. Walters, Y. Koh, M. Amano, and H. Mitsuya. Journal of Medicinal Chemistry, 2011. 54(2): p. 622-634; ISI[000286306400018].
[WOS], HIV_0218-030311.
19.Cross-Target View to Feature Selection: Identification of Molecular Interaction Features in Ligand-Target Space. Niijima, S., H. Yabuuchi, and Y. Okuno. Journal of Chemical Information and Modeling, 2011. 51(1): p. 15-24; ISI[000286444200004].
[WOS], HIV_0218-030311.
20. Synthesis, in vitro Antiproliferative and Anti-HIV Activity of New Derivatives of 2-Piperazino-1,3-benzo d thiazoles. Al-Soud, Y.A., H.H. Al-Sa'doni, S.O.W. Saber, R.H.M. Al-Shaneek, N.A. Al-Masoudi, R. Loddo, and P. La Colla. Zeitschrift Fur Naturforschung Section B-a Journal of Chemical Sciences, 2010. 65(11): p. 1372-1380; ISI[000286485500013].
[WOS], HIV_0218-030311.
21. Synthesis and Anti-HIV Activity of New 2-Thiolumazine and 2-Thiouracil Metal Complexes. Al-Masoudi, N.A., B.A. Saleh, N.A. Karim, A.Y. Issa, and C. Pannecouque. Heteroatom Chemistry, 2011. 22(1): p. 44-50; ISI[000286489300009].
[WOS], HIV_0218-030311.
22. Synthesis and antiviral bioactivities of novel chiral bis-thiourea-type derivatives containing alpha-aminophosphonate moiety. Yang, X.A., B.A. Song, L.H. Jin, X. Wei, S.P. Bhadury, X.Y. Li, S. Yang, and D.Y. Hu. Science China-Chemistry, 2011. 54(1): p. 103-109; ISI[000286498200013].
[WOS], HIV_0218-030311.
23. Isolation of optically active nevirapine, a dipyridodiazepinone metabolite from the seeds of Cleome viscosa. Chattopadhyay, S.K., A. Chatterjee, S. Tandon, P.R. Maulik, and R. Kant. Tetrahedron, 2011. 67(2): p. 452-454; ISI[000286499000021].
[WOS], HIV_0218-030311.
24. A Concise and Flexible Diastereoselective Approach to Heteroring-Fused Isoindolinones. Ahn, G., M. Lorion, V. Agouridas, A. Couture, E. Deniau, and P. Grandclaudon. Synthesis-Stuttgart, 2011(1): p. 147-153; ISI[000286506800025].
[WOS], HIV_0218-030311.
25. The Furan Approach to Oxacycles: New Entry to the Synthesis of Isodideoxynucleosides. Canoa, P., Z. Gandara, M. Perez, R. Gago, G. Gomez, and Y. Fall. Synthesis-Stuttgart, 2011(3): p. 431-436; ISI[000286508400012].
[WOS], HIV_0218-030311.
26. Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture. Chertov, O., N. Zhang, X. Chen, J.J. Oppenheim, J. Lubkowski, C. McGrath, R.C. Sowder, B.J. Crise, A. Malyguine, M.A. Kutzler, A.D. Steele, E.E. Henderson, and T.J. Rogers. PLoS ONE, 2011. 6(1); ISI[000286514000001].
[WOS], HIV_0218-030311.
Patent Citations:
27. Preparation of phenylsulfonylpyrrolidinylaminoethyl diphenylalaninamides as HIV protease inhibitors. Coburn, C.A., M.K. Holloway, and J.P. Vacca. 2010. 2010-US35200 2010138338.
[Patent]. HIV_0218-030311.
28. 1-(3-aminopropyl)piperazine-4-amino amide-like compounds, their preparation and application as anti-AIDs agents. Dai, Q., M. Dong, S. Jiang, and H. Lu. 2010. 2010-10182303
101921224.
[Patent]. HIV_0218-030311.
29. Anti-inflammatory and anti-HIV compositions and methods of use. Hillwig, M.L. 2010. 2008-129391 7854946.
[[Patent]. HIV_0218-030311.
30. Preparation of pyridinyl-substituted quinolinylamine derivatives useful for treating AIDS. Tazi, J., F. Mahuteau, and R. Najman. 2010. 2010-IB52651 2010143169.
[Patent]. HIV_0218-030311.
31. The use of an extract of helichrysum, for the treatment of HIV/AIDS. Harding, N.M., N. Moodley, P. Meoni, V.J. Maharaj, S.-W. Van Rooyen, M. Van der Merwe, and J.J.M. Meyer. 2011. 2009-IB52807 2011001208.
[Patent]. HIV_0218-030311.
32. (Heterocyclyl)azabicyclooctane derivatives as CCR5 antagonists and their preparation and use for the treatment of CCR5-mediated diseases. Duan, M., W.M. Kazmierski, and M. Tallant. 2011. 2010-US42992
2011011652.
[Patent]. HIV_0218-030311.
33. Extracts of medicinal plant and uses thereof. He, J.J., I.-W. Park, G. Chen, C. Han, and X. Song. 2011. 2010-US43542
2011014561.
[Patent]. HIV_0218-030311.
34. Hydroxyproline derivatives as HIV-1 protease inhibitors and their preparation, pharmaceutical compositions and use in the treatment of HIV infection. Liu, Z. and B. Gao. 2011. 2010-10246801
101948418.
[Patent]. HIV_0218-030311.
35. Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth. Lori, F., D. De Forni, and M.R. Stevens. 2011. 2010-US2091
2011014239.
[Patent]. HIV_0218-030311.
36. Preparation of lupeol-type triterpene derivatives as antiviral agents. Reddy, B.P., V.M. Sharma, K.R. Reddy, M.M. Reddy, N.Y. Reddy, and L.V.L. Subrahmanyam. 2011. 2010-IB1677
2011007230.
[Patent]. HIV_0218-030311.
37. Substituted bis(aryl)pyrazolecarboxamides having terminal primary amide functionalization for treating retroviral diseases and their preparation. Wildum, S., B. Klenke, H. Schirmer, J. Stiehl, and K.M. Gericke. 2011. 2010-EP60914
2011012630.
[Patent]. HIV_0218-030311.